Farther Finance Advisors, LLC
Position in NBIX — Neurocrine Biosciences Inc
CIK 1992825
SAN FRANCISCO, CA
Position in NBIX
as of Sep 30, 2026
· filed Oct 8, 2026
Position Value
$487,645
+$65,790 QoQ
Shares Held
3,438
+37.4% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#9
of 26 holders
Holding Since
Dec 2022
16 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in NBIX Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Sep 30, 2026Farther Finance Advisors, LLC holds $5,652,044 across 52 Drug Manufacturers - Specialty & Generic names. NBIX ranks #4 (8.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VTRS |
Viatris Inc
|
55,192 | $978,002 | |
| 2 | ZTS |
Zoetis Inc.
|
9,999 | $698,230 | |
| 3 | HIMS |
Hims & Hers Health, Inc.
|
17,335 | $516,409 | |
| 4 | NBIX |
Neurocrine Biosciences Inc
This page
|
3,438 | $487,645 | |
| 5 | TAK |
Takeda Pharmaceutical Co Ltd
|
25,420 | $462,389 | |
| 6 | UTHR |
UNITED THERAPEUTICS Corp
|
707 | $383,116 | |
| 7 | COLL |
Collegium Pharmaceutical, Inc
|
16,406 | $357,978 | |
| 8 | PBH |
Prestige Consumer Healthcare Inc.
|
7,117 | $326,456 |
All Filings in NBIX
Export CSV
16 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-09-30 | $487,645 | 3,438 | Shares | Sole | 2026-10-08 | |
| 2026-06-30 | $421,855 | 2,503 | Shares | Sole | 2026-07-17 | |
| 2026-03-31 | $388,237 | 2,947 | Shares | Sole | 2026-04-07 | |
| 2025-12-31 | $390,599 | 2,754 | Shares | Sole | 2026-01-23 | |
| 2025-09-30 | $159,190 | 1,134 | Shares | Sole | 2025-10-14 | |
| 2025-06-30 | $115,509 | 919 | Shares | Sole | 2025-07-11 | |
| 2025-03-31 | $75,871 | 686 | Shares | Sole | 2025-04-14 | |
| 2024-12-31 | $67,294 | 493 | Shares | Sole | 2025-02-10 | |
| 2024-09-30 | $50,927 | 442 | Shares | Sole | 2024-10-29 | |
| 2024-06-30 | $60,850 | 442 | Shares | Sole | 2024-07-31 | |
| 2024-03-31 | $59,995 | 435 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $56,656 | 430 | Shares | Sole | 2024-02-15 | |
| 2023-09-30 | $47,587 | 423 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $943 | 10 | Shares | Sole | 2024-05-14 | |
| 2023-03-31 | $506 | 5 | Shares | Sole | 2024-05-14 | |
| 2022-12-31 | $597 | 5 | Shares | Sole | 2023-09-12 | |
| No filing history on record for this holder in this stock. | ||||||